The 2025 Research Innovation Grants are supporting projects focused on biomarkers, risk factors, and treatments for ALS.

The FDA has approved Itvisma for the treatment of children two years and older, teens and adults living with spinal muscular ...

Parkinson's disease (PD) is an age-related, progressive neurodegenerative disorder. The hallmark of PD pathogenesis is the ...

Cure SMA, the leading nonprofit organization dedicated to supporting those impacted by spinal muscular atrophy (SMA), welcomes the FDA approval of Itvismatm (onasemnogene abeparvovec-brve) by Novartis ...

Neurizon® Therapeutics Limited (ASX: NUZ & NUZOA; OTCQB: NUZTF) ("Neurizon" or "the Company"), a clinical-stage biotech company dedicated ...

November 2011: Ashley Nelson and his wife Jean, of Terrington St Clement, were dismayed when two gnomes were stolen from ...

The province made a one-year commitment to pay for Bray’s treatment, which is estimated to cost $300,000 annually. Manitoba ...

Tremors: Slight shaking or tremor in your finger, thumb, hand or chin. The tremor usually happens at rest, and when you move ...

A new DoD-funded trial tests SwallowFIT, a targeted therapy that strengthens swallowing muscles in early Parkinson’s patients ...

Shares surged as investors reacted to a large equity offering combined with renewed optimism around Pasithea’s expanding ...

A strategic focus on collaboration between industry and academia is essential for sustaining growth and competitiveness in the pharma sector ...

Quickly approved by national drug authority Anvisa under priority review, the study positions Brazil at the forefront of the field in Latin America.